CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an ...
Hypertension is one of the most common chronic conditions in the U.S., affecting nearly half of the country’s adults, according to the Centers for Disease Control and Prevention. Unfortunately, ...